Touchlight
United Kingdom
Drug Product
Advanced Modalities
Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Others
Clinical Trial Supply & Logistics
Contract Research Organization
Company Overview
About
Touchlight is a UK-based CDMO pioneering enzymatic GMP DNA production using its proprietary cell-free dbDNA technology. Founded in 2007 and based in London, the company manufactures high-purity DNA for genetic medicines across applications including mRNA, AAV viral vectors, lentiviral vectors, gene editing, DNA vaccines, and non-viral gene therapy. Touchlight holds a world-first MHRA GMP certification for synthetic DNA manufacturing and has 9 programs in the clinic using dbDNA.
Key Expertise
Cell-free enzymatic DNA manufacturing, dbDNA technology, mRNA template production, viral vector support, GMP DNA
Therapeutic Areas
Oncology
Infectious Disease
Rare Diseases
Vaccines
Quick Facts
HQ:United Kingdom
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Viral Vectors
- Cell & Gene Therapy
Production Scales
R&D / Pre-clinical
Lab Scale
Pilot Scale
Phase I Clinical Trials
Phase II
Clinical
Commercial Scale
Annual Capacity
Small Batch / R&D (< 100 kg/year)
Medium Clinical (100 - 1,000 kg/year)
Markets Served
Europe
Manufacturing Facilities
1 site worldwide
Touchlight - United Kingdom Facility
United Kingdom
Site Capabilities
Solid Dose Manufacturing
Oral Liquids
Topicals
Certifications
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Customer Reviews
No reviews available yet.
Company Documents
No documents available.